M.E. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya, L.V. Poletaeva
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
|
№6 / 2017
|
L.A. Sharonova, A.F. Verbovoy, I.A. Tsanava
STATE OF CARDIOVASCULAR SYSTEM IN METABOLIC SYNDROME
|
№5 / 2017
|
A.F. Verbovoy, L.A. Sharonova, A.V. Pashentseva, I.A. Tsanava
INSULIN RESISTANCE SYNDROME IN THE CLINIC OF INTERNAL DISEASES
|
№5 / 2017
|
E.N. Shirokova
NONALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK (LITERATURE REVIEW)
|
№2 / 2017
|
L.V. Egshatyan (1), A.M. Mkrtumyan (1), L.A. Zvenigorodskaya (2)
METABOLIC SYNDROME AND INTESTINAL MICROBIOTA
|
№16 / 2016
|
N.M. Podzolkova, Yu.A. Koloda, M.B. Anshina, O.L. Glazkova
IVF/ICSI OUTCOMES IN WOMEN WITH OBESITY AND METABOLIC SYNDROME
|
№3 / 2016
|
E.V. Balukova (1), N.V. Baryshnikova (1), L.N. Belousova (2)
NONALCOHOLIC FATTY LIVER DISEASE: CURRENT STATE OF PROBLEM
|
№2 / 2016
|
E.A. Strebkova, L.I. Alekseeva
OSTEOARTHROSIS AND METABOLIC SYNDROME
|
№17 / 2015
|
E.Yu. Plotnikova (1), O.A. Krasnov (2, 3)
RELATIONSHIP BETWEEN MICROBIAL LANDSCAPE OF THE INTESTINE AND METABOLIC SYNDROME
|
№15 / 2015
|
V.S. Nikiforov
BLOOD VISCOSITY AS A TARGET OF THERAPEUTIC INTERVENTION IN CARDIOVASCULAR PATHOLOGY
|
№13 / 2015
|
N.B. Petrukhina (1, 2), O.A. Zorina (1, 2), I.M. Rabinovich (2), A.M. Shilov (1), A.M. Molchanov (2)
RESULTS OF EVALUATION OF BIOCHEMICAL, ANTIOXIDANT AND PRO-INFLAMMATORY STATUSES BEFORE AND AFTER TREATMENT OF CHRONIC GENERALIZED PERIODONTITIS IN PATIENTS WITH METABOLIC SYNDROME
|
№s2-15 / 2015
|
O.A. Gromova (1, 2), I.Yu. Torshin (2, 3), O.A. Limanova (1, 2), T.R. Grishina (1), A.N. Gromov (3)
VITAMIN D CONCENTRATIONS AND METABOLIC DISORDERS: SYSTEMATIC ANALYSIS OF THE FUNDAMENTAL AND EVIDENCE-BASED STUDIES ON THE PROBLEM OF OVERWEIGHT AND DIABETES MELLITUS
|
№20 / 2014
|